Intensification and consolidation therapy in multiple myeloma in the current era

Lancet Haematol. 2020 Jun;7(6):e427-e429. doi: 10.1016/S2352-3026(20)30110-1. Epub 2020 Apr 30.

Authors

Omar Nadeem¹, Irene M Ghobrial²

Affiliations

¹ Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. Electronic address: omar_nadeem@dfci.harvard.edu.
² Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.

PMID: 32359505
DOI: 10.1016/S2352-3026(20)30110-1

No abstract available

Publication types

Comment

MeSH terms

Bortezomib
Consolidation Chemotherapy
Humans
Lenalidomide
Multiple Myeloma*

Substances

Bortezomib
Lenalidomide